Cargando…

β-Adrenergic cAMP Signals Are Predominantly Regulated by Phosphodiesterase Type 4 in Cultured Adult Rat Aortic Smooth Muscle Cells

BACKGROUND: We investigated the role of cyclic nucleotide phosphodiesterases (PDEs) in the spatiotemporal control of intracellular cAMP concentrations in rat aortic smooth muscle cells (RASMCs). METHODOLOGY/PRINCIPAL FINDINGS: The rank order of PDE families contributing to global cAMP-PDE activity w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Kui, Hubert, Fabien, Nicolas, Valérie, Ji, Guangju, Fischmeister, Rodolphe, Leblais, Véronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475707/ https://www.ncbi.nlm.nih.gov/pubmed/23094097 http://dx.doi.org/10.1371/journal.pone.0047826

Ejemplares similares

Phosphodiesterases and cAMP Pathway in Pituitary Diseases
por: Bizzi, Mariana Ferreira, et al.
Publicado: (2019)

Interventricular Differences in β‐Adrenergic Responses in the Canine Heart: Role of Phosphodiesterases
por: Molina, Cristina E., et al.
Publicado: (2014)

Functional Analysis of Two Affinity cAMP Phosphodiesterases in the Nematode-Trapping Fungus Arthrobotrys oligospora
por: Ma, Ni, et al.
Publicado: (2022)

An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing
por: Johnson, Keven R, et al.
Publicado: (2010)

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases
por: Park, Sung-Jun, et al.
Publicado: (2012)

Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection
por: Evripioti, Antonia Alexandra, et al.
Publicado: (2019)

Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
por: Ponsaerts, Laura, et al.
Publicado: (2021)

A cAMP phosphodiesterase is essential for sclerotia formation and virulence in Sclerotinia sclerotiorum
por: Xu, Yan, et al.
Publicado: (2023)

Impaired cAMP processivity by phosphodiesterase-protein kinase A complexes in acrodysostosis
por: Venkatakrishnan, Varun, et al.
Publicado: (2023)

Membranes prime the RapGEF EPAC1 to transduce cAMP signaling
por: Sartre, Candice, et al.
Publicado: (2023)

Expression and function of phosphodiesterases (PDEs) in the rat urinary bladder
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
por: Mokni, Walid, et al.
Publicado: (2010)

Evolution of multiple phosphodiesterase isoforms in stickleback involved in cAMP signal transduction pathway
por: Sato, Yukuto, et al.
Publicado: (2009)

Overexpression of the Rv0805 phosphodiesterase elicits a cAMP-independent transcriptional response()
por: Matange, Nishad, et al.
Publicado: (2013)

Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4
por: Perera, Ruwan K., et al.
Publicado: (2017)

Phosphodiesterase beta is the master regulator of cAMP signalling during malaria parasite invasion
por: Flueck, Christian, et al.
Publicado: (2019)

Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in Toxoplasma gondii
por: Vo, Kim Chi, et al.
Publicado: (2022)

Erratum to: Expression and function of phosphodiesterases (PDEs) in the rat urinary bladder
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes
por: Brzezinska, Paulina, et al.
Publicado: (2021)

The Role of Type 4 Phosphodiesterases in Generating Microdomains of cAMP: Large Scale Stochastic Simulations
por: Oliveira, Rodrigo F., et al.
Publicado: (2010)

Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins
por: Tibbo, Amy J., et al.
Publicado: (2022)

The cAMP effector EPAC activates Elk1 transcription factor in prostate smooth muscle, and is a minor regulator of α1-adrenergic contraction
por: Hennenberg, Martin, et al.
Publicado: (2013)

Opening up to cAMP Transport Mechanisms in Airway Smooth Muscle
por: Huff, Ryan D., et al.
Publicado: (2021)

Inhibition of cAMP phosphodiesterase by milrinone improves cardiac recovery after deep hypothermic circulatory arrest
por: Troitzsch, D, et al.
Publicado: (2001)

Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts
por: Cho, Eun Sook, et al.
Publicado: (2005)

The cAMP phosphodiesterase Prune localizes to the mitochondrial matrix and promotes mtDNA replication by stabilizing TFAM
por: Zhang, Fan, et al.
Publicado: (2015)

Nucleotide signaling pathway convergence in a cAMP‐sensing bacterial c‐di‐GMP phosphodiesterase
por: Cadby, Ian T, et al.
Publicado: (2019)

Mitochondrial sub-cellular localization of cAMP-specific phosphodiesterase 8A in ovarian follicular cells
por: Lounas, Amel, et al.
Publicado: (2019)

Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts
por: Calamera, Gaia, et al.
Publicado: (2022)

Distribution of adenylyl cyclase/cAMP phosphodiesterase gene, CAPE, in streptophytes reproducing via motile sperm
por: Yamamoto, Chiaki, et al.
Publicado: (2021)

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-α release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors
por: Hichami, A., et al.
Publicado: (1996)

Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP
por: Smith, Sarah A., et al.
Publicado: (2019)

Transcription factors regulated by cAMP in smooth muscle of the myometrium at human parturition
por: Li, Jonathan K.H., et al.
Publicado: (2021)

The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP
por: McKean, Jenny S., et al.
Publicado: (2015)

Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways
por: Chu, Simeng, et al.
Publicado: (2020)

EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase
por: Song, G, et al.
Publicado: (2014)

Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
por: Niu, Miaomiao, et al.
Publicado: (2013)

Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior
por: Bolger, Graeme B., et al.
Publicado: (2020)

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
por: Kurelic, Roberta, et al.
Publicado: (2021)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
por: Lugnier, Claire
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ia05liahr7e11336m6ksenjva8